Literature DB >> 17263149

Reactive gingival lesions: a retrospective study of 2,439 cases.

Weiping Zhang1, Yu Chen, Zhiguo An, Ning Geng, Dongmei Bao.   

Abstract

OBJECTIVE: To identify the clinicopathologic features of epulides in West China and to compare these data with those of previous studies from other countries. METHOD AND MATERIALS: Demographics; clinical data including gender, age, and chief complaints of the patients; and the type, size and location, duration, diagnosis, and histologic features of the lesion were studied from among biopsy specimens and clinical records at West China College of Stomatology from January 1951 to July 2005.
RESULTS: A total of 2,439 epulides were identified. Epulides found were peripheral fibroma (PF: 1,489, 61.05%), peripheral ossifying fibroma (POF: 431, 17.67%), pyogenic granuloma (PG: 482, 19.76%), and peripheral giant cell granuloma (PGCG: 37, 1.52%). The total ratio of males to females was 1:1.40. Specifically, the ratios were 1:1.31 for PF, 1:1.99 for PG, and 1:1.47 for PGCG (all P < .001). The peak incidence of epulides fell in the third to sixth decade of life overall, the fifth to sixth decade for PF and POF, and the third to fourth decade for PG.
CONCLUSIONS: Among the 4 kinds of reactive lesions, PF had the highest incidence and PG had the lowest incidence in Chinese patients. There were also differences in type, sex, age, location, duration, and histologic features: PF was the most common type; all of the epulides except PGCG showed a predilection for females; PG was more prevalent among young patients; and POF lasted much longer than other lesions. Differences in the distribution of the 4 types of lesion were also found among various ethnic groups.

Entities:  

Mesh:

Year:  2007        PMID: 17263149

Source DB:  PubMed          Journal:  Quintessence Int        ISSN: 0033-6572            Impact factor:   1.677


  24 in total

1.  Epulis: a study of 92 cases with special emphasis on histopathological diagnosis and associated clinical data.

Authors:  Astrid Truschnegg; Stephan Acham; Birgit Alexandra Kiefer; Norbert Jakse; Alfred Beham
Journal:  Clin Oral Investig       Date:  2015-11-18       Impact factor: 3.573

Review 2.  Giant peripheral ossifying fibroma: a case report and clinicopathologic review of 10 cases from the literature.

Authors:  Esther L B Childers; Iris Morton; Cheryl E Fryer; Babak Shokrani
Journal:  Head Neck Pathol       Date:  2013-07-16

3.  A rare massive exophytic gingival growth.

Authors:  Suvy Manuel; Surej L K Kumar; Bindu J Nair
Journal:  Clin Pract       Date:  2012-03-05

4.  Peripheral ossifying fibroma on edentulous mandibular alveolar mucosa.

Authors:  Sanjay Joshi; Sima Mazumdar; Manish Kumar Pandit
Journal:  J Maxillofac Oral Surg       Date:  2011-12-23

5.  Reactive hyperplasia of the oral cavity: a survey of 197 cases in tabriz, northwest iran.

Authors:  Amir Ala Aghbali; Sepideh Vosough Hosseini; Bahram Harasi; Maryam Janani; Seyyed Mostafa Mahmoudi
Journal:  J Dent Res Dent Clin Dent Prospects       Date:  2010-09-16

6.  Management of unusual case of Crocker and Hartzell's disease in a young patient with a 1 year follow-up.

Authors:  Yash Bafna; H V Kambalimath; Vishal Khandelwal; Prathibha Anand Nayak
Journal:  BMJ Case Rep       Date:  2013-05-22

7.  Effective management of focal reactive gingival overgrowths by diode laser: A review and report of two cases.

Authors:  Madhu S Ratre; Pratik A Chaudhari; Shaleen Khetarpal; Pratiksha Kumar
Journal:  Laser Ther       Date:  2019-12-31

8.  A giant cell fibroma and focal fibrous hyperplasia in a young child: a case report.

Authors:  Rodney J Vergotine
Journal:  Case Rep Dent       Date:  2012-06-03

9.  Reactive lesions of the oral cavity: A retrospective study on 2068 cases.

Authors:  Noushin Jalayer Naderi; Nosratollah Eshghyar; Hora Esfehanian
Journal:  Dent Res J (Isfahan)       Date:  2012-05

10.  Orthodontic elastic separator-induced periodontal abscess: a case report.

Authors:  Talia Becker; Alex Neronov
Journal:  Case Rep Dent       Date:  2012-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.